Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LONBRECA: Lonsurf in Metastatic Breast Cancer
NCT04280536Phase 2Active, not recruiting
- Sponsor
- National University Hospital
- Start
- Aug 2019
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in breast cancer, sponsored by National University Hospital. Started Aug 2019; status: active, not recruiting.
02
Drugs
trifluridine + tipiracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04280536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04280536.